Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances · Bedford, MA, United States

  1. PrincipalsAmanda Michelle MorganChief Commercial OfficerKimberly BrownChief Accounting OfficerRobert J. Marshall Jr.CFO and Treasurerand 3 more
  2. CompanyLantheus Holdings, Inc.Bedford, MA, United States
  3. Phone line+1 (978) 671-8001General business
Request a quote

Lantheus Holdings, Inc. is an SEC-registered Nasdaq-listed company (ticker LNTH) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions

People 6

Chair & board

Mary Anne HeinoExecutive Chair

Finance

Kimberly BrownChief Accounting Officer
Robert J. Marshall Jr.CFO and Treasurer

Sales & commercial

Amanda Michelle MorganChief Commercial Officer
Everyone else on file (2)
Daniel NiedzwieckiOfficer (see SEC filing)
Ludger DinkelborgOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Kimberly Brown — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Robert J. Marshall Jr. — CFO and Treasurer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Daniel Niedzwiecki — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Amanda Michelle Morgan — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers